Friends! In this video, im going to discuss my 3 worst stock market picks based on the mistakes I've made and what I learned from them.
2 extracted signals · 2 resolved · 0 still active
The Patient Investor10 Aug 2025, 17:23 UTC
AI-generated source summary
The analysis focuses on three stocks (UNH, WALMEX and MUSA), providing insight on investment mistakes. The first stock discussed is UnitedHealth Group (UNH). The analyst bought UnitedHealth at $420 per share. The current share price is $244.67, representing a 41% decline. It is suggested investors need a catalyst for growth and may need a President to endorse stocks before people buy. For Wal-Mart de Mexico (WALMEX), a 6% loss after the stock price remained stagnant over five years. For Murphy USA(MUSA), the investors didn't focused on quality. AutoZone (AZO) was a better option but was more expensive than MUSA, which currently trades around $377. Inferred targets are also provided.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Signals in this source
More Prediction Case Files from The Patient Investor
Why I Don't Own Google Stock & When I'm Buying
The CHEAPEST Quality Stock In The Stock Market!
Intuitive Surgical Stock Analysis! Risks & Upside Potential
There Is NO AI BUBBLE! I’m Buying Every Dip
2 Stocks I'm Buying In The Next 2 Weeks
Netflix Stock Is FINALLY A Buy!
The Patient Investor
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

